1,593
Views
9
CrossRef citations to date
0
Altmetric
Research Paper

Metabolism-related long non-coding RNAs (lncRNAs) as potential biomarkers for predicting risk of recurrence in breast cancer patients

, , & ORCID Icon
Pages 3726-3736 | Received 18 May 2021, Accepted 03 Jul 2021, Published online: 13 Jul 2021

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Xue Zeng, Xinchi Ma, Hong Guo, Linlin Wei, Yaotian Zhang, Chaonan Sun, Ning Han, Shichen Sun & Na Zhang. (2021) MicroRNA-582-5p promotes triple-negative breast cancer invasion and metastasis by antagonizing CMTM8. Bioengineered 12:2, pages 10126-10135.
Read now
Shaojie Qin, Mingliang Ning, Qingyuan Liu, Xiaoyun Ding, Yanbai Wang & Qilun Liu. (2021) Knockdown of long non-coding RNA CDKN2B-AS1 suppresses the progression of breast cancer by miR-122-5p/STK39 axis. Bioengineered 12:1, pages 5125-5137.
Read now

Articles from other publishers (6)

Xin Ge, Shu Lei, Panliang Wang, Wenkang Wang & Wendong Wang. (2024) The metabolism-related lncRNA signature predicts the prognosis of breast cancer patients. Scientific Reports 14:1.
Crossref
Cristian Arriaga-Canon, Laura Contreras-Espinosa, Sergio Aguilar-Villanueva, Enrique Bargalló-Rocha, José Antonio García-Gordillo, Paula Cabrera-Galeana, Clementina Castro-Hernández, Francisco Jiménez-Trejo & L. A. Herrera. (2023) The Clinical Utility of lncRNAs and Their Application as Molecular Biomarkers in Breast Cancer. International Journal of Molecular Sciences 24:8, pages 7426.
Crossref
Afshin Bahramy, Narges Zafari, Fatemeh Rajabi, Amirhossein Aghakhani, Ahmad Jayedi, Alireza Soltani Khaboushan, Masoumeh Majidi Zolbin & Mir Saeed Yekaninejad. (2023) Prognostic and diagnostic values of non-coding RNAs as biomarkers for breast cancer: An umbrella review and pan-cancer analysis. Frontiers in Molecular Biosciences 10.
Crossref
Jinsong Liu, Yuyang Dai, Yueyao Lu, Xiuling Liu, Jianzhong Deng, Wenbin Lu & Qian Liu. (2023) Identification and validation of a new pyroptosis-associated lncRNA signature to predict survival outcomes, immunological responses and drug sensitivity in patients with gastric cancer. Mathematical Biosciences and Engineering 20:2, pages 1856-1881.
Crossref
Chuigong Yu, Yu Fan, Yu Zhang, Lupeng Liu & Gang Guo. (2022) LINC00893 inhibits the progression of prostate cancer through miR-3173-5p/SOCS3/JAK2/STAT3 pathway. Cancer Cell International 22:1.
Crossref
Xu Wang, Ke Chen, Zhenglin Wang, Yuanmin Xu, Longfei Dai, Tao Bai, Bo Chen, Wenqi Yang & Wei Chen. (2021) Using Immune-Related Long Non-coding Ribonucleic Acids to Develop a Novel Prognosis Signature and Predict the Immune Landscape of Colon Cancer. Frontiers in Cell and Developmental Biology 9.
Crossref